Company: NDRA
Filing Date: 2025-10-28
Form Type: DEF 14A
Source: 0001654954-25-012254
Chunk: 49

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-10-28
Form: DEF 14A
Chunk 49
---
 The Board believes that the interests of the Company and its stockholders will be advanced if we can continue to offer our officers, non-employee directors, key employees, consultants, and advisors the opportunity to acquire or increase a direct proprietary interest in the Company. In connection with its continuous evaluation of the Company’s compensation program, the Board has determined that it is in the best interest of the Company to approve, subject to further stockholder approval, the 2016 Plan Amendment.

The following table provides certain information regarding our outstanding equity awards and the 2016 Plan (with performance-based awards included at the “maximum” level) as of the record date. As of the record date, there were 1,166,441 shares of our common stock outstanding. The closing price of our common stock as reported on Nasdaq on the record date was $7.00 per share.

| 36 |

| Shares Subject to Outstanding Restricted Stock Unit Awards   
 Shares Subject to Outstanding Stock Options                  
 Weighted Average Remaining Term of Outstanding Stock Options |     |   |   147,169 
       266 
      4.48 |
|:-------------------------------------------------------------|:----|:--|----------:|
| Weighted Average Exercise Price of Outstanding Stock Options |     | $ | 26,594.61 |
| Shares Relating to Outstanding Full-Value Awards             |     |   |   147,169 |
| Shares Remaining Available for Issuance under the 2016 Plan  |     |   |    32,336 |

Material Features of 2016 Plan, as Amended by the 2016 Plan Amendment

The material terms of the 2016 Plan, as amended by the 2016 Plan Amendment, are summarized below. This summary of the 2016 Plan is not intended to be a complete description of the plan, as amended by the 2016 Plan Amendment, and is qualified in its entirety by the terms of the 2016 Plan. The proposed changes to the 2016 Plan as a result of the 2016 Plan Amendment are set forth in Appendix B.

Purpose

The 2016 Plan is intended to enhance the ability of the Company and its affiliates to attract and retain highly qualified officers, non-employee directors, employees, consultants and advisors. To this end, the 2016 Plan provides for the grant of stock options, SARs, restricted stock, RSUs, unrestricted stock, other share-based awards and cash awards. Any of these awards may, but need not, be